TrialAnnals of the rheumatic diseases2015

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis.

D L Boyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.